Literature DB >> 34209939

Fundamentals, Diagnostic Capabilities and Perspective of Narrow Band Imaging for Early Gastric Cancer.

Hiroki Kurumi1, Kouichi Nonaka2, Yuichiro Ikebuchi1, Akira Yoshida1, Koichiro Kawaguchi1, Kazuo Yashima1, Hajime Isomoto1.   

Abstract

The development of image-enhanced endoscopy has dramatically improved the qualitative and quantitative diagnosis of gastrointestinal tumors. In particular, narrow band imaging (NBI) has been widely accepted by endoscopists around the world in their daily practice. In 2009, Yao et al. proposed vessel plus surface (VS) classification, a diagnostic algorithm for early gastric cancer using magnifying endoscopy with NBI (ME-NBI), and in 2016, Muto et al. proposed a magnifying endoscopy simple diagnostic algorithm for early gastric cancer (MESDA-G) based on VS classification. In addition, the usefulness of ME-NBI in the differential diagnosis of gastric cancer from gastritis, diagnosis of lesion extent, inference of histopathological type, and diagnosis of depth has also been investigated. In this paper, we narrative review the basic principles, current status, and future prospects of NBI.

Entities:  

Keywords:  gastric cancer; image-enhanced endoscopy; narrow band imaging; red dichromatic imaging; texture and color enhancement imaging

Year:  2021        PMID: 34209939     DOI: 10.3390/jcm10132918

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  2 in total

1.  Photodynamic Diagnosis for the Identification of Intestinal-Type Gastric Cancers and High-Grade Adenomas.

Authors:  Hiroki Kurumi; Takuki Sakaguchi; Keiichi Hashiguchi; Taro Yamashita; Masashi Fujii; Yuichiro Ikebuchi; Akira Yoshida; Hajime Isomoto
Journal:  Front Oncol       Date:  2022-05-02       Impact factor: 6.244

2.  TXI (Texture and Color Enhancement Imaging) for Serrated Colorectal Lesions.

Authors:  Toshihiro Nishizawa; Osamu Toyoshima; Shuntaro Yoshida; Chie Uekura; Ken Kurokawa; Munkhbayar Munkhjargal; Miho Obata; Tomoharu Yamada; Mitsuhiro Fujishiro; Hirotoshi Ebinuma; Hidekazu Suzuki
Journal:  J Clin Med       Date:  2021-12-27       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.